Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00661804 · ClinicalTrials.gov registry record

Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study

A clinical trial, sponsored by Carelon Research.

Completed
Registry status
416
Enrollment target

NCT00661804 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 416 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00661804 has completed, sponsored by Carelon Research.

COMPLETED
Registry status
416 participants
Enrollment target

Study Summary

Thalassemias are inherited blood disorders that can cause anemia and other health problems. The goal of this study is to collect information on complications of the disease among people who currently have or previously had thalassemia.

Trial Details

FieldValue
Enrollment Target 416 participants
Start Date 2007-05
Est. Completion 2011-06

Sponsor

Carelon Research

50 total trials

What the Registry Record Tells You About NCT00661804

The ClinicalTrials.gov registry entry for NCT00661804 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 416 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carelon Research, which has 50 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00661804 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00661804 about?

NCT00661804 is a clinical study titled "Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study". Thalassemias are inherited blood disorders that can cause anemia and other health problems. The goal of this study is to collect information on complications of the disease among people who currently have or previously had thalassemia.

What is the current status of trial NCT00661804?

This trial is currently completed. The enrollment target is 416 participants. The study started on 2007-05. Estimated completion is 2011-06.

Who is sponsoring clinical trial NCT00661804?

This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.